PT1781298E - Combinações farmacêuticas contendo benzoxazinas para o tratamento de doenças respiratórias - Google Patents

Combinações farmacêuticas contendo benzoxazinas para o tratamento de doenças respiratórias Download PDF

Info

Publication number
PT1781298E
PT1781298E PT05739576T PT05739576T PT1781298E PT 1781298 E PT1781298 E PT 1781298E PT 05739576 T PT05739576 T PT 05739576T PT 05739576 T PT05739576 T PT 05739576T PT 1781298 E PT1781298 E PT 1781298E
Authority
PT
Portugal
Prior art keywords
respiratory diseases
pharmaceutical combinations
treating respiratory
combinations containing
containing benzoxazine
Prior art date
Application number
PT05739576T
Other languages
English (en)
Inventor
Michel Pairet
Christoph Hoenke
Klaus Rudolf
Ingo Konetzki
Philipp Lustenberger
Thierry Bouyssou
Andreas Schnapp
Michael P Pieper
Sabine Pestel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1781298(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de
Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PT1781298E publication Critical patent/PT1781298E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
PT05739576T 2004-04-22 2005-04-18 Combinações farmacêuticas contendo benzoxazinas para o tratamento de doenças respiratórias PT1781298E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004019540A DE102004019540A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de) 2004-11-03 2004-11-03 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496 2005-02-07

Publications (1)

Publication Number Publication Date
PT1781298E true PT1781298E (pt) 2012-02-03

Family

ID=34966478

Family Applications (2)

Application Number Title Priority Date Filing Date
PT111870382T PT2422786E (pt) 2004-04-22 2005-04-18 Novas combinações farmacêuticas para o tratamento de doenças respiratórias
PT05739576T PT1781298E (pt) 2004-04-22 2005-04-18 Combinações farmacêuticas contendo benzoxazinas para o tratamento de doenças respiratórias

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT111870382T PT2422786E (pt) 2004-04-22 2005-04-18 Novas combinações farmacêuticas para o tratamento de doenças respiratórias

Country Status (31)

Country Link
EP (2) EP2422786B1 (pt)
JP (1) JP2007533683A (pt)
KR (2) KR20130049840A (pt)
AR (1) AR049262A1 (pt)
AT (1) ATE539754T1 (pt)
AU (1) AU2005235419B2 (pt)
BR (1) BRPI0510080B8 (pt)
CA (1) CA2559699C (pt)
CY (3) CY1113890T1 (pt)
DK (2) DK2422786T3 (pt)
EA (1) EA013157B1 (pt)
EC (1) ECSP066947A (pt)
ES (2) ES2380370T3 (pt)
FI (1) FIC20170005I1 (pt)
HU (1) HUS1500058I1 (pt)
IL (2) IL177685A (pt)
LT (1) LTC1781298I2 (pt)
LU (1) LU93066I2 (pt)
MY (1) MY148945A (pt)
NL (1) NL300779I2 (pt)
NO (2) NO337714B1 (pt)
NZ (1) NZ550797A (pt)
PE (1) PE20060462A1 (pt)
PL (2) PL1781298T4 (pt)
PT (2) PT2422786E (pt)
SG (1) SG152237A1 (pt)
SI (2) SI2422786T1 (pt)
TW (2) TWI374739B (pt)
UY (1) UY28861A1 (pt)
WO (1) WO2005102349A1 (pt)
ZA (1) ZA200606624B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7923455B2 (en) * 2005-01-28 2011-04-12 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
EP1855689A1 (en) * 2005-02-16 2007-11-21 Boehringer Ingelheim International GmbH Pharmaceutical compositions comprising anticholinergics and etiprednol
CN101208316B (zh) 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 制备β-模拟物的方法
US20070088030A1 (en) * 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
US20070086957A1 (en) * 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
WO2007058971A2 (en) * 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic esters
WO2007093608A1 (de) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
US20090324510A1 (en) 2006-08-07 2009-12-31 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
JP2010507617A (ja) * 2006-10-26 2010-03-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器系及び消化器系障害の治療用の新規な医薬組成物
EP1921070A1 (de) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
AU2009211523B2 (en) 2008-02-07 2014-03-13 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
CA2733153C (en) 2008-08-08 2016-11-08 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
JP2012509922A (ja) * 2008-11-27 2012-04-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規粉末化結晶質吸入薬
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
EP2906218B1 (en) 2012-10-09 2016-12-14 Boehringer Ingelheim International GmbH Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
EP1305300A1 (de) 2000-04-27 2003-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Neue, langwirksame betamimetika, verfahren zu deren herstellung und deren verwendung als arzneimittel
HU226830B1 (en) 2000-10-12 2009-11-30 Boehringer Ingelheim Pharma Thiotropium bromide monohydrate, method for producing the same and a pharmaceutical composition containing the same
DK1401445T3 (da) 2001-06-22 2006-11-27 Boehringer Ingelheim Pharma Krystallinsk anticholinergikum, fremgangsmåde til fremstilling af dette og anvendelse af dette til fremstilling af et lægemiddel
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
CY1113890T1 (el) 2016-07-27
AU2005235419B2 (en) 2010-11-04
SG152237A1 (en) 2009-05-29
SI1781298T1 (sl) 2012-04-30
PL1781298T4 (pl) 2017-07-31
ECSP066947A (es) 2007-01-26
LU93066I2 (fr) 2016-07-11
ES2380370T3 (es) 2012-05-11
NL300779I2 (nl) 2017-11-02
JP2007533683A (ja) 2007-11-22
IL177685A (en) 2013-10-31
BRPI0510080A (pt) 2007-10-16
CY1115719T1 (el) 2017-01-25
NO337714B1 (no) 2016-06-06
FIC20170005I1 (fi) 2017-01-13
NO2016022I1 (no) 2016-12-01
IL226562A0 (en) 2013-06-27
TWI374739B (en) 2012-10-21
ATE539754T1 (de) 2012-01-15
EP2422786A1 (de) 2012-02-29
CY2017014I2 (el) 2017-11-14
ES2523518T3 (es) 2014-11-26
NO2016022I2 (no) 2016-12-01
PE20060462A1 (es) 2006-06-19
CA2559699C (en) 2012-06-19
TW201231055A (en) 2012-08-01
KR101287460B1 (ko) 2013-07-23
PL2422786T3 (pl) 2015-02-27
UY28861A1 (es) 2005-11-30
PT2422786E (pt) 2014-11-12
CA2559699A1 (en) 2005-11-03
EP2422786B1 (de) 2014-08-13
HUS1500058I1 (hu) 2016-01-28
BRPI0510080B1 (pt) 2020-08-18
NZ550797A (en) 2010-08-27
IL177685A0 (en) 2006-12-31
KR20130049840A (ko) 2013-05-14
KR20070015592A (ko) 2007-02-05
TWI372056B (en) 2012-09-11
PL1781298T3 (pl) 2012-06-29
WO2005102349A1 (de) 2005-11-03
EA013157B1 (ru) 2010-02-26
EP1781298B1 (de) 2012-01-04
NO20065060L (no) 2006-11-21
EA200601846A1 (ru) 2007-04-27
AU2005235419A1 (en) 2005-11-03
DK1781298T3 (da) 2012-05-07
BRPI0510080B8 (pt) 2021-05-25
MY148945A (en) 2013-06-14
DK2422786T3 (da) 2014-11-17
CY2017014I1 (el) 2017-11-14
LTC1781298I2 (lt) 2018-09-25
ZA200606624B (en) 2008-01-08
AR049262A1 (es) 2006-07-12
SI2422786T1 (sl) 2014-12-31
EP1781298A1 (de) 2007-05-09

Similar Documents

Publication Publication Date Title
HUS1500058I1 (hu) Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
IL177663A0 (en) Benzoxazine for treating respiratory tract diseases
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
ZA200701584B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
ZA200610640B (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
IL180931A0 (en) Medicaments for treating chronic respiratory disease
EP1806148A4 (en) THERAPEUTIC PREPARATION FOR INHALATION
EP1962869A4 (en) TREATMENT OF RESPIRATORY DISEASES
IL190652A0 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
IL185444A0 (en) Novel drugs for treating respiratory diseases
IL197125A0 (en) Drug combinations for treating airway diseases
HK1104427A1 (en) Medicine volatilizer
EP1731171A4 (en) PREVENTATIVE MEDICINE / REMEDY FOR RESPIRATORY DISEASES
EP1719514A4 (en) MEDICAMENT FOR TREATING PAIN
ZA200606780B (en) Compounds for the treatment of diseases
PL373154A1 (en) Pharmaceutical composition intended for treating nasal cavity
GB0420867D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
TWI350171B (en) Pharmaceutical compositions for treatment of cardio-cerebral-vascular diseases
GB0405805D0 (en) Therapeutic treatment for tinnitus
HU0400847D0 (en) Pharmaceutical composition for the treatment of diabetes
AU2005904004A0 (en) Compounds for medicinal treatment
IL186916A0 (en) Use of insp052 polypeptide for the preparation of a medicament for treating diseases